Insider trades
David C. Myles, Ch. Discov. & Non-clin Dev Off of Olema Pharmaceuticals OLMA, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $4.7M. The latest trade was on 02/02.
David C. Myles
Ch. Discov. & Non-clin Dev Off
- Company
- Olema Pharmaceuticals OLMA
- First filing
- 23/02/02
- Trades
- 31 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- −$4.7M
- Last trade
- 02/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
OLMA | Open-market sale | 01/12–01/14 | 01/14 | 110,000 sh5 trades | $28.25avg. | $3,107,229.17 | No record |
OLMA | Open-market sale | 25/12/19 | 25/12/23 | 51,000 sh3 trades | $30.46avg. | $1,553,543.54 | −8.5% |
OLMA | Open-market sale | 24/12/10–24/12/11 | 24/12/11 | 26,066 sh3 trades | $9.01avg. | $234,916 | −4.2% |
OLMA | Open-market sale | 23/11/21–23/11/22 | 23/11/22 | 13,629 sh3 trades | $14.40avg. | $196,233.29 | −2.3% |
| Open-market sale10b5-1 plan | 23/11/08 | 23/11/13 | 200 sh | $17.61 | $3,522 | −0.0% | |
OLMA | Open-market sale10b5-1 plan | 23/11/01–23/11/03 | 23/11/03 | 10,541 sh3 trades | $15.26avg. | $160,805.79 | −1.8% |
| Open-market sale10b5-1 plan | 23/09/19 | 23/09/21 | 20,000 sh | $12.67 | $253,400 | −3.4% |